Last reviewed · How we verify
SP IPT
SP IPT is a vaccine that targets the SARS-CoV-2 spike protein.
SP IPT is a vaccine that targets the SARS-CoV-2 spike protein. Used for COVID-19 prevention.
At a glance
| Generic name | SP IPT |
|---|---|
| Also known as | SP, Fansidar (R) |
| Sponsor | Institute of Tropical Medicine, Belgium |
| Drug class | vaccine |
| Target | SARS-CoV-2 spike protein |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
The vaccine works by inducing an immune response against the spike protein, which is a key component of the SARS-CoV-2 virus. This immune response helps to prevent infection and reduce the severity of COVID-19 symptoms.
Approved indications
- COVID-19 prevention
Common side effects
- Pain, redness, or swelling at the injection site
- Fatigue
- Headache
Key clinical trials
- MDA and Targeted Control Against Plasmodium Carriage in the Sahel (NA)
- Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi (PHASE4)
- Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy (NA)
- Intermittent Preventive Treatment of Malaria in Schoolchildren (PHASE3)
- Efficacy of Psychotherapy for Depressed Parkinson's Disease Patients (NA)
- Comparing Chemoprevention Drugs for School-based Malaria Control (PHASE4)
- Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG) (PHASE3)
- Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SP IPT CI brief — competitive landscape report
- SP IPT updates RSS · CI watch RSS
- Institute of Tropical Medicine, Belgium portfolio CI